Tag: Flu
In Early Trial, Results Promising for Moderna Combo COVID-Flu Vaccine
Moderna hopes to get federal regulatory approval for the combined vaccine in 2025
Immune Response Not Inferior With Coadministration of COVID-19, Flu Shots
Similar immune response and no increase in rate of reactogenicity events seen with coadministration versus COVID-19 vaccine alone
Flu Vaccine Cut Risk for Influenza-Linked Hospitalizations in 2023
Interim data show vaccine effectiveness of 51.9 percent in five South American countries during their flu season
Recommendations Updated for Flu Vaccine in Children
Providers may administer whichever product is appropriate and readily available to achieve the highest possible coverage
Incidence of New-Onset HTN Higher for COVID-19 Versus Influenza Patients
Hospitalized and nonhospitalized patients with COVID-19 more likely to develop persistent HTN than those with influenza
Oseltamivir Not Linked to Reduced Risk for Flu Hospitalization
No reduced risk seen among older patients, those at risk for hospitalization
Physical Activity Affects Flu, Pneumonia Mortality
Aerobic activity, even below recommended level, linked to lower mortality, while J-shaped pattern seen for muscle-strengthening activity
Flu-Related Hospitalization Rates Higher for Indigenous People
Across high-income nations, higher disparities seen during the pandemic
Electronic Reminders Boost Flu Vaccine Uptake in Older Adults
Letters highlighting potential cardiovascular benefits of influenza vaccination found to be particularly effective
Flu Vaccine Effective for 2022/2023 Season
Vaccine effectiveness 54 percent against medically attended outpatient acute respiratory infection associated with influenza A in patients younger than 65 years
